ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

HSPB1/KDM1 A facilitates ANXA2 expression via hypomethylated DNA promoter to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer.

Liuxu Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.